ImageneBio, Inc. (IMA)Healthcare | Biotechnology | San Diego, United States | NasdaqCM
6.11 USD
+0.20
(3.384%)
⇧
(July 13, 2026, 4 p.m.
EDT)
After hours: 6.11 |
Hot Take ↕ | July 11, 2026, 6:03 a.m. EDT
The immediate outlook is severely clouded by a massive liquidity crisis. While the company recently secured $30 million in private funding, the stock is trading at a fraction of its book value ($5.91 vs $10.93) because the market is pricing in an imminent bankruptcy scenario driven by relentless cash burn. Operating cash flow is draining at -$55 million annually, and the free cash flow is nearly -$27 million, meaning the recent capital raise is merely extending a runway that is already critically short. The balance sheet, while technically showing a high current ratio due to cash reserves, cannot sustain these burn rates without further dilution or a successful clinical trial outcome, neither of which is guaranteed. Fundamentally, the business is deteriorating rapidly; the stock has lost over 90% of its value over the last four years, with the most recent annual performance showing another double-digit decline. This is not a value opportunity; it is a distressed asset where the probability of total loss outweighs the speculative upside of a potential drug approval. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.030460 |
| MSTL | 0.031507 |
| MSTL_126 | 0.042027 |
| AutoTheta | 0.049976 |
| MSTL_90 | 0.067882 |
| MSTL_90_126 | 0.076977 |
| AutoARIMA | 0.119987 |
Forecast horizon: 60 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 41% |
| H-stat | 1.30 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.160 |
| Excess Kurtosis | -0.42 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 1.959 |
| Market Cap | 68,915,488 |
| Forward P/E | -1.54 |
| Previous Name | Inmagene Biopharmaceuticals Co. Ltd. |
| Website | https://www.inmagenebio.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.6405109 |
| Address1 | 12,526 High Bluff Drive |
| Address2 | Suite 345 |
| All Time High | 451.32 |
| All Time Low | 3.94 |
| Ask | 7.66 |
| Ask Size | 2 |
| Audit Risk | 10 |
| Average Daily Volume10 Day | 8,310 |
| Average Daily Volume3 Month | 45,309 |
| Average Volume | 45,309 |
| Average Volume10Days | 8,310 |
| Bid | 4.45 |
| Bid Size | 2 |
| Board Risk | 8 |
| Book Value | 10.934 |
| City | San Diego |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 10 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 6.11 |
| Current Ratio | 18.391 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 6.2999 |
| Day Low | 5.9001 |
| Debt To Equity | 1.959 |
| Display Name | ImageneBio |
| Ebitda | -54,038,248 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | 0.849 |
| Enterprise Value | -45,876,516 |
| Eps Current Year | -4.10333 |
| Eps Forward | -3.98 |
| Eps Trailing Twelve Months | -4.8 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 5.7563 |
| Fifty Day Average Change | 0.35370016 |
| Fifty Day Average Change Percent | 0.06144575 |
| Fifty Two Week Change Percent | -64.051094 |
| Fifty Two Week High | 18.0 |
| Fifty Two Week High Change | -11.889999 |
| Fifty Two Week High Change Percent | -0.66055554 |
| Fifty Two Week Low | 3.94 |
| Fifty Two Week Low Change | 2.17 |
| Fifty Two Week Low Change Percent | 0.55076146 |
| Fifty Two Week Range | 3.94 - 18.0 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,616,765,400,000 |
| Float Shares | 5,804,579 |
| Forward Eps | -3.98 |
| Forward P E | -1.5351759 |
| Free Cashflow | -27,264,376 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 17 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,782,864,000 |
| Gross Margins | 0.0 |
| Gross Profits | 0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.11261 |
| Held Percent Institutions | 0.4816 |
| Implied Shares Outstanding | 11,279,130 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,753,660,800 |
| Last Split Factor | 1:12 |
| Long Business Summary | ImageneBio, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for patients with immunological, autoimmune and inflammatory diseases. Its lead product candidate includes IMG-007, a non-depleting anti-OX40 monoclonal antibody that binds to OX40 receptor on activated T cells to block receptor binding to OX40 ligand which is in Phase 1b/2a clinical trial. The company was formerly known as Ikena Oncology, Inc. and changed its name to ImageneBio, Inc. in July 2025. ImageneBio, Inc. is headquartered in San Diego, California. |
| Long Name | ImageneBio, Inc. |
| Market | us_market |
| Market Cap | 68,915,488 |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_689254445 |
| Most Recent Quarter | 1,774,915,200 |
| Name Change Date | 2,026-07-13 |
| Net Income To Common | -53,886,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 68,577,110 |
| Number Of Analyst Opinions | 1 |
| Open | 5.98 |
| Operating Cashflow | -55,414,000 |
| Operating Margins | 0.0 |
| Overall Risk | 10 |
| Payout Ratio | 0.0 |
| Phone | 858 345 6265 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 6.11 |
| Post Market Time | 1,783,973,404 |
| Prev Name | Inmagene Biopharmaceuticals Co. Ltd. |
| Previous Close | 5.91 |
| Price Eps Current Year | -1.4890345 |
| Price Hint | 2 |
| Price To Book | 0.5588074 |
| Price To Sales Trailing12 Months | Infinity |
| Profit Margins | 0.0 |
| Quick Ratio | 17.668 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.2 |
| Regular Market Change Percent | 3.3841 |
| Regular Market Day High | 6.2999 |
| Regular Market Day Low | 5.9001 |
| Regular Market Day Range | 5.9001 - 6.2999 |
| Regular Market Open | 5.98 |
| Regular Market Previous Close | 5.91 |
| Regular Market Price | 6.11 |
| Regular Market Time | 1,783,972,801 |
| Regular Market Volume | 12,527 |
| Return On Assets | -0.45615003 |
| Return On Equity | -0.86155 |
| Revenue Per Share | 0.0 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 10 |
| Shares Outstanding | 11,279,130 |
| Shares Percent Shares Out | 0.0359 |
| Shares Short | 404,370 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 445,327 |
| Short Name | ImageneBio, Inc. |
| Short Percent Of Float | 0.0364 |
| Short Ratio | 27.06 |
| Source Interval | 15 |
| State | CA |
| Symbol | IMA |
| Target High Price | 24.0 |
| Target Low Price | 24.0 |
| Target Mean Price | 24.0 |
| Target Median Price | 24.0 |
| Total Cash | 117,208,000 |
| Total Cash Per Share | 10.392 |
| Total Debt | 2,416,000 |
| Total Revenue | 0 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -4.8 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 6.54581 |
| Two Hundred Day Average Change | -0.4358101 |
| Two Hundred Day Average Change Percent | -0.06657848 |
| Type Disp | Equity |
| Volume | 12,527 |
| Website | https://www.inmagenebio.com |
| Zip | 92,130 |